← FDA DRUG APPROVALS

FDA ANDA · ANDA087100

CHLORTHALIDONE

Sponsor: WATSON LABS

APPLICATION
ANDA087100
TYPE
ANDA
ORIGINAL APPROVAL
1981-08-25
LATEST ACTION
1998-07-17
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CHLORTHALIDONEDiscontinued
CHLORTHALIDONE 25MG · TABLET · ORAL

Approval history

1998-07-17Manufacturing (CMC) · Supplement 28AP
1997-01-31Manufacturing (CMC) · Supplement 27AP
1996-03-26Labeling · Supplement 26AP
1989-03-01Labeling · Supplement 25AP
1988-11-08Manufacturing (CMC) · Supplement 23AP
1988-11-08Manufacturing (CMC) · Supplement 21AP
1988-11-08Manufacturing (CMC) · Supplement 22AP
1988-10-14Labeling · Supplement 24AP
1988-07-27Manufacturing (CMC) · Supplement 19AP
1988-06-07Labeling · Supplement 20AP
1988-04-04Manufacturing (CMC) · Supplement 16AP
1988-02-25Manufacturing (CMC) · Supplement 17AP
1988-02-25Manufacturing (CMC) · Supplement 18AP
1987-12-04Manufacturing (CMC) · Supplement 14AP
1987-04-03Manufacturing (CMC) · Supplement 13AP
1985-12-10Manufacturing (CMC) · Supplement 9AP
1985-12-10Manufacturing (CMC) · Supplement 11AP
1985-12-10Manufacturing (CMC) · Supplement 12AP
1984-02-09Manufacturing (CMC) · Supplement 7AP
1983-12-09Manufacturing (CMC) · Supplement 6AP
1982-12-20Manufacturing (CMC) · Supplement 2AP
1981-08-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →